Carmed Pharmaceuticals Expands U.S. Presence with Launch on OneLavi.com

Carmed Pharmaceuticals, a Turkey-based science-driven company specializing in standardized carvacrol-based formulations, announced that select products are now available on OneLavi.com, a curated online marketplace focused on beauty, health, and wellness brands. The launch marks another milestone in Carmed's ongoing expansion into the United States market and follows the company's previously announced plans to broaden availability through multiple digital retail channels, including Amazon.

Carmed's approach combines traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed to support immune resilience, cellular health, and overall physiological balance.

Through OneLavi.com, U.S. consumers can now access several of Carmed Pharmaceuticals' flagship formulations, including Vacrol® Kids Spray, S-Mix®, Vacrol® Capsule, and Vacrol-M® Capsule. Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified. According to the company, all formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across production.

Carmed states that OneLavi's curated marketplace aligns with the company's long-term strategy of introducing its formulations through platforms that emphasize quality, product transparency, and wellness-focused discovery. “Launching on OneLavi represents an important step in making our formulations accessible to consumers in the United States,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “We believe curated wellness platforms provide an environment where consumers can better understand the value of standardized, research-driven formulations.”

Carmed's formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science. In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to broader scientific investigation involving carvacrol-based formulations and multicomponent botanical interactions. The company emphasizes that this research reflects scientific investigation into botanical bioactivity and formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Carmed states that its U.S. strategy is focused on long-term brand development through scientific credibility, regulatory alignment, and expanded consumer accessibility. “We are excited to officially introduce Carmed to OneLavi's wellness-focused audience,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “This launch supports our broader vision of building a trusted international wellness brand as we continue expanding throughout the United States.”

Consumers can learn more and shop Carmed Pharmaceuticals products at OneLavi.com: Vacrol® Kids Spray, S-Mix®, Vacrol® Capsule, and Vacrol-M® Capsule.